100,000 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by Venator Management LLC

Venator Management LLC bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $1,344,000. Oscar Health comprises about 0.4% of Venator Management LLC’s investment portfolio, making the stock its 20th largest holding.

A number of other institutional investors and hedge funds also recently modified their holdings of OSCR. Vanguard Group Inc. increased its stake in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock valued at $255,333,000 after buying an additional 586,626 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the period. State Street Corp raised its holdings in Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after purchasing an additional 291,335 shares in the last quarter. BIT Capital GmbH raised its holdings in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock worth $92,062,000 after purchasing an additional 455,205 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on OSCR shares. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Oscar Health has an average rating of “Hold” and a consensus target price of $20.21.

Oscar Health Trading Down 1.4 %

NYSE OSCR opened at $13.29 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $12.43 and a 12 month high of $23.79. The company has a market capitalization of $3.33 billion, a PE ratio of -663.92 and a beta of 1.75. The stock has a 50-day simple moving average of $14.90 and a 200 day simple moving average of $16.05.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.